M&R Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $319K | Buy |
6,170
+624
| +11% | +$29.3K | 0.07% | 103 |
|
|
2024
Q2 | $230K | Sell |
5,546
-89
| -2% | -$3.98K | 0.05% | 122 |
|
|
2024
Q1 | $306K | Sell |
5,635
-537
| -9% | -$27.4K | 0.07% | 106 |
|
|
2023
Q4 | $317K | Sell |
6,172
-2,542
| -29% | -$133K | 0.08% | 111 |
|
|
2023
Q3 | $506K | Sell |
8,714
-2,467
| -22% | -$151K | 0.14% | 84 |
|
|
2023
Q2 | $715K | Sell |
11,181
-1,845
| -14% | -$124K | 0.19% | 71 |
|
|
2023
Q1 | $903K | Sell |
13,026
-663
| -5% | -$46.8K | 0.25% | 59 |
|
|
2022
Q4 | $985K | Buy |
13,689
+4,309
| +46% | +$325K | 0.27% | 56 |
|
|
2022
Q3 | $666K | Buy |
9,380
+1,750
| +23% | +$127K | 0.19% | 75 |
|
|
2022
Q2 | $587K | Buy |
7,630
+235
| +3% | +$17.9K | 0.15% | 88 |
|
|
2022
Q1 | $540K | Buy |
7,395
+1,895
| +34% | +$127K | 0.12% | 97 |
|
|
2021
Q4 | $342K | Sell |
5,500
-700
| -11% | -$41.1K | 0.07% | 120 |
|
|
2021
Q3 | $366K | Buy |
6,200
+200
| +3% | +$13.2K | 0.08% | 115 |
|
|
2021
Q2 | $400K | Hold |
6,000
| – | – | 0.09% | 114 |
|
|
2021
Q1 | $378K | Sell |
6,000
-1,140
| -16% | -$70.9K | 0.09% | 106 |
|
|
2020
Q4 | $442K | Sell |
7,140
-592
| -8% | -$36.4K | 0.1% | 112 |
|
|
2020
Q3 | $466K | Buy |
7,732
+400
| +5% | +$24.1K | 0.12% | 106 |
|
|
2020
Q2 | $430K | Sell |
7,332
-13,032
| -64% | -$779K | 0.12% | 111 |
|
|
2020
Q1 | $1.14M | Sell |
20,364
-1,378
| -6% | -$84.2K | 0.34% | 64 |
|
|
2019
Q4 | $1.39M | Buy |
21,742
+150
| +0.7% | +$8.59K | 0.31% | 72 |
|
|
2019
Q3 | $1.09M | Sell |
21,592
-300
| -1% | -$14.1K | 0.25% | 85 |
|
|
2019
Q2 | $992K | Hold |
21,892
| – | – | 0.22% | 89 |
|
|
2019
Q1 | $1M | Sell |
21,892
-2,052
| -9% | -$102K | 0.23% | 86 |
|
|
2018
Q4 | $1.24M | Sell |
23,944
-5,900
| -20% | -$317K | 0.32% | 68 |
|
|
2018
Q3 | $1.85M | Sell |
29,844
-300
| -1% | -$17.8K | 0.4% | 60 |
|
|
2018
Q2 | $1.67M | Sell |
30,144
-1,111
| -4% | -$60K | 0.38% | 59 |
|
|
2018
Q1 | $1.98M | Buy |
31,255
+1,902
| +6% | +$122K | 0.46% | 54 |
|
|
2017
Q4 | $1.8M | Sell |
29,353
-667
| -2% | -$41.7K | 0.42% | 52 |
|
|
2017
Q3 | $1.91M | Sell |
30,020
-500
| -2% | -$29.2K | 0.46% | 53 |
|
|
2017
Q2 | $1.73M | Sell |
30,520
-647
| -2% | -$35.2K | 0.43% | 52 |
|
|
2017
Q1 | $1.69M | Sell |
31,167
-6
| -0% | -$329 | 0.43% | 55 |
|
|
2016
Q4 | $1.82M | Buy |
31,173
+200
| +0.6% | +$10.9K | 0.49% | 52 |
|
|
2016
Q3 | $1.67M | Buy |
30,973
+1,956
| +7% | +$126K | 0.47% | 55 |
|
|
2016
Q2 | $2.13M | Buy |
29,017
+75
| +0.3% | +$5.3K | 0.62% | 46 |
|
|
2016
Q1 | $1.85M | Buy |
28,942
+236
| +0.8% | +$14.9K | 0.56% | 49 |
|
|
2015
Q4 | $1.98M | Buy |
28,706
+1,553
| +6% | +$103K | 0.57% | 49 |
|
|
2015
Q3 | $1.61M | Sell |
27,153
-2,098
| -7% | -$133K | 0.44% | 53 |
|
|
2015
Q2 | $1.95M | Sell |
29,251
-497
| -2% | -$32.8K | 0.46% | 55 |
|
|
2015
Q1 | $1.92M | Sell |
29,748
-1,077
| -3% | -$67.4K | 0.45% | 55 |
|
|
2014
Q4 | $1.82M | Buy |
30,825
+603
| +2% | +$34K | 0.43% | 58 |
|
|
2014
Q3 | $1.55M | Sell |
30,222
-196
| -0.6% | -$9.79K | 0.37% | 62 |
|
|
2014
Q2 | $1.48M | Sell |
30,418
-147
| -0.5% | -$7.24K | 0.35% | 61 |
|
|
2014
Q1 | $1.59M | Buy |
30,565
+4
| +0% | +$213 | 0.38% | 54 |
|
|
2013
Q4 | $1.62K | Sell |
30,561
-181
| -0.6% | -$9.22K | 0.43% | 50 |
|
|
2013
Q3 | $1.42M | Buy |
30,742
+38
| +0.1% | +$1.67K | 0.4% | 53 |
|
|
2013
Q2 | $1.37M | Buy |
+30,704
| New | +$1.33M | 0.4% | 53 |
|
Other funds holding BMY
M&R Capital Management's BMY Position: Q3 2024 in Review
M&R Capital Management increased its Bristol-Myers Squibb (BMY) stake by 11% in Q3 2024, buying an estimated $29.3K and bringing the position to 6,170 shares worth $319K. The position accounts for 0.07% of the portfolio, ranked #103.
M&R Capital Management first reported a position in BMY in Q2 2013 and has held it in 46 quarters since. The position peaked at $2.13M in Q2 2016. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.
- M&R Capital Management held 6,170 shares of Bristol-Myers Squibb worth $319K as of Q3 2024.
- M&R Capital Management bought 624 Bristol-Myers Squibb shares in Q3 2024, an estimated $29.3K.
- Bristol-Myers Squibb made up 0.07% of M&R Capital Management's portfolio in Q3 2024, its #103 holding.
- M&R Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 46 quarters since.
- M&R Capital Management's Bristol-Myers Squibb position peaked at $2.13M in Q2 2016.
- 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.
Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.